COVID-19 Information

Edit Entry | Edit CV

Mary F. Brunette, MD

Professor of Psychiatry
Professor of Community and Family Medicine
Professor of The Dartmouth Institute

Additional Titles/Positions/Affiliations:
Medical Director, Bureau of Mental Health Services, NH Dept of Health and Human Services
Co-Director, Northern New England Post-Doctoral Primary Care Research Training Program
Co-DIrector, Community Engaged Research Core, Dartmouth SYNERGY, CTSA
Chairman, NH DHHS Committee for the Protection of Human Subjects
Co-Investigator, Ctr for Technology & Behavioral Health

Community and Family Medicine
The Dartmouth Institute

Lewis & Clark College, BA 1985
Oregon Health Sciences University, MD 1991

C. Everett Koop Institute at Dartmouth
Norris Cotton Cancer Center
Psychopharmacology Research Group

Contact Information:

Department of Psychiatry, Dartmouth-Hitchcock
Center for Technology and Behavioral Health
46 Centerra Parkway, level 2
Lebanon NH 0

Phone: 603-646-7019

Assistant: Brian Goodness
Asst. Email:

Professional Interests:

The goal of my research is to better understand the causes of addiction in vulnerable, complex populations, and to develop effective and disseminable treatment interventions for addiction in these groups by using a translational science approach that includes basic science, patient-oriented treatment and population-based studies.

In addition, I am engaged with public mental health administration in which I advance improvements in care for people with serious mental illness and multiple comorbidities.

Grant Information:

ProHealth NH: New Hampshire Partnerships to Improve Health & Wellness for Young People with SED and SMI

1H79SM080245-01 Substance Abuse and Mental Health Administration

Cannabis, schizophrenia and reward: Self-Medication and agonist

1R01DA034699-01 National Institute on Drug Abuse

Comparative effectiveness of integrated vs. referral-based care for pregnant women with opioid use disorder (Lord and Goodman, Multiple PIs)

MAT-2017C2-7717 PCORI

Stemming the Tide: The Role of Payment and Delivery System Reform in
Combating the Opioid Epidemic (Colla PI)

4R01-DA049757-01A1 National Institute on Drug Abuse

Mentoring Information:

I currently lead several large studies, including a trial using functional magnetic resonance imaging to assess the impact of cannabis on brain reward function in schizophrenia, and the implementation of integrated primary care and community mental health.

I am trained as an “Entering Mentoring” Facilitator, with a goal of increasing quality, equity and inclusion in science mentoring. I mentor research trainees on a variety of projects across the translational range - from a secondary analyses describing substance use in young adults with multiple morbidities, to a literature review of impact of cannabis on psychosis, to usability testing of apps for the treatment of addiction, and a qualitative study of a learning community to support statewide implementation of clinical services.

Selected Publications:


Validation of an Index for Functionally Important Respiratory Symptoms among Adults in the Nationally Representative Population Assessment of Tobacco and Health Study, 2014-2016.
Halenar MJ, Sargent JD, Edwards KC, Woloshin S, Schwartz L, Emond J, Tanski S, Pierce JP, Taylor KA, Lauten K, Goniewicz ML, Niaura R, Anic G, Chen Y, Callahan-Lyon P, Gardner LD, Thekkudan T, Borek N, Kimmel HL, Cummings KM, Hyland A, Brunette MF
Int J Environ Res Public Health. 2021 Sep 14;18(18) pii: 9688. doi: 10.3390/ijerph18189688. Epub 2021 Sep 14.
PMID: 34574610

Integrated vs nonintegrated treatment for perinatal opioid use disorder: retrospective cohort study.
Goodman DJ, Saunders EC, Frew JR, Arsan C, Xie H, Bonasia KL, Flanagan VA, Lord SE, Brunette MF
Am J Obstet Gynecol MFM. 2021 Sep 17;4(1):100489. doi: 10.1016/j.ajogmf.2021.100489. Epub 2021 Sep 17.
PMID: 34543754

The Impact of THC and CBD in Schizophrenia: A Systematic Review.
Ahmed S, Roth RM, Stanciu CN, Brunette MF
Front Psychiatry. 2021;12:694394. doi: 10.3389/fpsyt.2021.694394. Epub 2021 Jul 23.
PMID: 34366924

Usability and Acceptability of Two Smartphone Apps for Smoking Cessation Among Young Adults With Serious Mental Illness: Mixed Methods Study.
Gowarty MA, Longacre MR, Vilardaga R, Kung NJ, Gaughan-Maher AE, Brunette MF
JMIR Ment Health. 2021 Jul 7;8(7):e26873. doi: 10.2196/26873. Epub 2021 Jul 7.
PMID: 34255699

Acceptability and Usability of Mobile Apps for Smoking Cessation Among Young Adults With Psychotic Disorders and Other Serious Mental Illness.
Gowarty MA, Aschbrenner KA, Brunette MF
Front Psychiatry. 2021;12:656538. doi: 10.3389/fpsyt.2021.656538. Epub 2021 May 7.
PMID: 34025477

In Memory of Alan I. Green.
Brunette MF
J Dual Diagn. 2021 Apr-Jun;17(2):99-100. doi: 10.1080/15504263.2021.1904178. Epub 2021 Apr 19.
PMID: 33872116

Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.
Stanciu CN, Brunette MF, Teja N, Budney AJ
Psychiatr Serv. 2021 Apr 1;72(4):429-436. doi: 10.1176/ Epub 2021 Feb 3.
PMID: 33530732

Workshop on Implementation Science and Digital Therapeutics for Behavioral Health.
Lord SE, Campbell ANC, Brunette MF, Cubillos L, Bartels SM, Torrey WC, Olson AL, Chapman SH, Batsis JA, Polsky D, Nunes EV, Seavey KM, Marsch LA
JMIR Ment Health. 2021 Jan 28;8(1):e17662. doi: 10.2196/17662. Epub 2021 Jan 28.
PMID: 33507151

Perceptions of Mobile Apps for Smoking Cessation Among Young People in Community Mental Health Care: Qualitative Study.
Gowarty MA, Kung NJ, Maher AE, Longacre MR, Brunette MF
JMIR Form Res. 2020 Oct 2;4(10):e19860. doi: 10.2196/19860. Epub 2020 Oct 2.
PMID: 33006560

Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial.
Brunette MF, Correll CU, O'Malley SS, McDonnell D, DiPetrillo L, Jiang Y, Simmons A, Silverman BL, Citrome L, Green AI
J Clin Psychiatry. 2020 Mar 10;81(2) pii: 19m12786. doi: 10.4088/JCP.19m12786. Epub 2020 Mar 10.
PMID: 32160422

View more publications on PubMed